Study: Clot-busting drug OK for stroke patients on mild anticoagulants

03/15/2013 | HealthDay News

Giving tissue plasminogen activator to patients suffering a stroke who have been taking aspirin or the anticoagulant clopidogrel is not likely to cause fatal brain bleeding, a study published in the journal Academic Emergency Medicine found. Researchers examined data from more than 800 tPA-treated stroke patients and found no significant difference in the brain bleeding rate between patients taking clopidogrel or aspirin and those not taking either drug. The findings might not apply to patients taking warfarin, heparin, dabigatran or rivaroxaban, researchers noted.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA